Review Article
Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis
Table 1
The main characteristics of the included studies.
| | Author and year | Age | Female
(Gp210 antibodies (+)/Gp210 antibodies (-)) | Numbers of patients
(Gp210 antibodies (+)/Gp210 antibodies (-)) | Numbers of patients suffered from poor prognosis or death
(Gp210 antibodies (+)/Gp210 antibodies (-)) | Level of ALT (U/L), ALP (U/L), TBIL (mg/dl), and IgM (mg/dl)
(Gp210 antibodies (+)/Gp210 antibodies (-)) | Treatment period (months)
(Gp210 antibodies (+)/
Gp210 antibodies (-)) | Race |
| | Itoh S. et al., 1998 [14] | vs. | 12/101 | 25/88 | Other types of poor prognosis: 11/16
Liver failure type: 8/8
Died: 10/12 | ALT:
ALP:
TBIL:
IgM: | | Japan | | Nakamura M. et al., 2005 [15] | vs. | 9/63 | 23/48 | Liver failure type: 6/2
Died: 4/1 | ALT:
ALP:
TBIL:
IgM: | | Japan | | Nakamura M. et al., 2007 [16] | | 20/197 | 43/174 | Other types of poor prognosis: 6/10
Liver failure type: 6/1 | Na | | Japan | | Yang J. et al., 2009 [17] | vs. | 17/43 | 15/45 | Na | ALT:
ALP:
TBIL:
IgM: | Na | China | | Yang F. et al., 2017 [11] | | 23/253 | 133/143 | Other types of poor prognosis: 26/11
Died: 40/21 | Na | | China |
|
|
